Galderma will share exciting results from the Sculptra® Cheek Wrinkle study showing the long-lasting effectiveness and safety of Sculptra, as well as high aesthetic improvement and patient satisfaction over two years[i]
Galderma will present nine posters spanning its full aesthetics portfolio at AMWC 2026, highlighting the regenerative benefits of Sculptra®, the long-lasting efficacy of Restylane®, and the advanced clinical performance of Relfydess® (RelabotulinumtoxinA) 1-9
The data reinforce Galderma’s future-focused approach to innovation, addres
FACE by Galderma™ is a cutting-edge aesthetic visualization application that simulates the results of injectable treatments in real time, using digital facial assessment
The application provides advanced wrinkle detection as well as the possible results of 19 injectable treatments, which are displayed as dynamic “before and afte
Strong clinical data supporting Alluzience® (abobotulinumtoxinA, ABO), the first liquid, ready-to-use neuromodulator as an effective and well-tolerated treatment for glabellar (frown) lines, with a rapid onset and long duration of action of up to six months
Data confirming that Dysport® was consistently efficacious for the treatment of frown lines, was wel
Results 151 - 155 of 162
Page 31 of 33
Confirm navigation
You are about to leave the Galderma global site. Are you sure you want to leave this page?
